Executive Director
Pfizer
Groton, Connecticut
Adam Gilbert was born in New York City and raised in Chappaqua, NY. He majored in chemistry at Haverford College and graduated cum laude/with honors with a B.A. in chemistry. He received his Ph.D. with Professor Thomas Katz at Columbia University and completed a postdoc with Professor William Wulff at the University of Chicago. He joined the Medical Research Division of American Cyanamid in Pearl River, NY which became Wyeth-Ayerst Research and finally Wyeth Research.
Adam joined Pfizer in February 2010 as an Associate Research Fellow and a lab head in charge of the Experimental Design Chemistry – a group that focused on key portfolio projects with challenging medicinal chemistry design issues including covalent inhibitors, allosteric GPCR modulators, and chemoproteomics. His group helped deliver PF-06651600 (ritlecitinib), a covalent JAK3/Tec inhibitor currently in Phase 2b/3 trials for Alopecia Areata. Adam is currently an Executive Director in charge of Pfizer’s Design and Synthesis Sciences (DSS) Group. DSS is a platform medchem group located in Pfizer’s Discovery Sciences Department in Groton, CT which helps drive key Pfizer initiatives such as protein degradation, DNA-encoded library chemistry, and selection analysis, covalent inhibitor design, vaccine protein/LNP design, small molecule purification, and small molecule NMR.
Disclosure information not submitted.
Wednesday, October 19, 2022
8:30 AM – 9:00 AM ET
Wednesday, October 19, 2022
9:00 AM – 10:30 AM ET
Wednesday, October 19, 2022
1:30 PM – 2:30 PM ET